MAGMA
30 Nov 2021
MAGMA
ACTRN12620000048987
A multi-arm multi-stage, multi-centre, phase III (MAMS) platform trial that aims to assess hypotheses against a common standard-of-care control arm for the management of people with glioblastoma.
Medical Research Future Fund
Cancer Type | Brain & central nervous system |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | All stages |
Anticipated Start Date | 2020-09-15 |
Anticipated End Date | 2023-06-30 |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alison Richards |
Alison.Richards@sa.gov.au | |
Phone | 08 8206 4835 |
Principal Investigator | Dr Anna Mislang |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs